PiMedBio

Company

Seonggu Ro

PhD CEO

Drug R&D (> 30 years)

Major Experiences

Next generation NSAIDs: Pre-clinical & clinical development, NDA (Korea) filing & approval , drug reimbursement, marketing support
Anti-bacterial agent specific for S.aureus: Drug design to proof-of-concept in human
Targeted anti-cancer agent: Drug design to Phase 1b/2 for 2 indications.
2 early stage candidates: discovery & out-licensing to US companies
Several strategic collaborations with global pharma and biotech (Astra-Zeneca, Daiich-Sankyo, …..)

Awards

“Jang Young-Sil Award” 2016
“Silver-Tower Industry Medal” by President of Korea, 2015
“Minister Award for the Industrial Technology” 2015
“Minister Award for the Contribution to Advancement of Healthcare Technology in Research Field” 2014
“2009 Top 100 Researches in Korea”
“New Intellectual” 2002

Donggyu Shin

PhD CTO

Drug R&D (> 20 years)

Korea Drug Development Fund (Senior Researcher)
Samsung Advanced Institute of Technology (Research Staff Member, Protein Drug Design & Informatics)
KAIST (Ph.D., Drug Design & Informatics)
CrystalGenomics, Inc. (Principal Scientist, Drug Design & Informatics)
LG Life Science (Scientist, Drug Design & Informatics)
Seoul University(BS & MS,Chemistry & Physical Chemistry)

Major Experiences

Project evaluation & management of numerous drug discovery & development projects for grants.
Discovery of antibody drugs and novel biologics
Involved in the discovery of 2 Phase II clinical stage projects (Anti-bacterial agent specific for S.aureus, targeted anti-cancer agent)
Drug design in many other projects (one candidate was licensed out and several strategic collaborations with global pharma and biotech)

Skills & Techniques